C135H132F7N29O10S2 — CID 158321979
1-[4-(2-aminopyrimidin-5-yl)phenyl]-N-(4,5-dimethyl-1,3-thiazol-2-yl)cyclobutane-1-carboxamide;4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-[3-fluoro-4-(trifluoromethyl)phenyl]oxane-4-carboxamide;4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-isoquinolin-3-yloxane-4-carboxamide;1-[4-(2-aminopyrimidin-5-yl)phenyl]-N-(5-methyl-2-pyridinyl)cyclobutane-1-carboxamide;1-[4-(2-aminopyrimidin-5-yl)phenyl]-N-(5-methyl-1,3-thiazol-2-yl)cyclobutane-1-carboxamide;4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-[2-morpholin-4-yl-5-(trifluoromethyl)phenyl]oxane-4-carboxamide (PubChem CID 158321979) has the molecular formula C135H132F7N29O10S2 and a molecular weight of 2517.85 g/mol. Its IUPAC name is 1-[4-(2-aminopyrimidin-5-yl)phenyl]-N-(4,5-dimethyl-1,3-thiazol-2-yl)cyclobutane-1-carboxamide;4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-[3-fluoro-4-(trifluoromethyl)phenyl]oxane-4-carboxamide;4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-isoquinolin-3-yloxane-4-carboxamide;1-[4-(2-aminopyrimidin-5-yl)phenyl]-N-(5-methyl-2-pyridinyl)cyclobutane-1-carboxamide;1-[4-(2-aminopyrimidin-5-yl)phenyl]-N-(5-methyl-1,3-thiazol-2-yl)cyclobutane-1-carboxamide;4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-[2-morpholin-4-yl-5-(trifluoromethyl)phenyl]oxane-4-carboxamide.
| Compound Name | 1-[4-(2-aminopyrimidin-5-yl)phenyl]-N-(4,5-dimethyl-1,3-thiazol-2-yl)cyclobutane-1-carboxamide;4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-[3-fluoro-4-(trifluoromethyl)phenyl]oxane-4-carboxamide;4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-isoquinolin-3-yloxane-4-carboxamide;1-[4-(2-aminopyrimidin-5-yl)phenyl]-N-(5-methyl-2-pyridinyl)cyclobutane-1-carboxamide;1-[4-(2-aminopyrimidin-5-yl)phenyl]-N-(5-methyl-1,3-thiazol-2-yl)cyclobutane-1-carboxamide;4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-[2-morpholin-4-yl-5-(trifluoromethyl)phenyl]oxane-4-carboxamide |
|---|---|
| PubChem CID | 158321979 |
| Molecular Formula | C135H132F7N29O10S2 |
| Molecular Weight | 2517.85 g/mol |
| Exact Mass | 2516.00 |
| IUPAC Name | 1-[4-(2-aminopyrimidin-5-yl)phenyl]-N-(4,5-dimethyl-1,3-thiazol-2-yl)cyclobutane-1-carboxamide;4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-[3-fluoro-4-(trifluoromethyl)phenyl]oxane-4-carboxamide;4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-isoquinolin-3-yloxane-4-carboxamide;1-[4-(2-aminopyrimidin-5-yl)phenyl]-N-(5-methyl-2-pyridinyl)cyclobutane-1-carboxamide;1-[4-(2-aminopyrimidin-5-yl)phenyl]-N-(5-methyl-1,3-thiazol-2-yl)cyclobutane-1-carboxamide;4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-[2-morpholin-4-yl-5-(trifluoromethyl)phenyl]oxane-4-carboxamide |
| SMILES | Cc1ccc(NC(=O)C2(c3ccc(-c4cnc(N)nc4)cc3)CCC2)nc1.Cc1cnc(NC(=O)C2(c3ccc(-c4cnc(N)nc4)cc3)CCC2)s1.Cc1nc(NC(=O)C2(c3ccc(-c4cnc(N)nc4)cc3)CCC2)sc1C.Nc1ncc(-c2ccc(C3(C(=O)Nc4cc(C(F)(F)F)ccc4N4CCOCC4)CCOCC3)cc2)cn1.Nc1ncc(-c2ccc(C3(C(=O)Nc4cc5ccccc5cn4)CCOCC3)cc2)cn1.Nc1ncc(-c2ccc(C3(C(=O)Nc4ccc(C(F)(F)F)c(F)c4)CCOCC3)cc2)cn1 |
| InChI | InChI=1S/C27H28F3N5O3.C25H23N5O2.C23H20F4N4O2.C21H21N5O.C20H21N5OS.C19H19N5OS/c28-27(29,30)21-5-6-23(35-9-13-38-14-10-35)22(15-21)34-24(36)26(7-11-37-12-8-26)20-3-1-18(2-4-20)19-16-32-25(31)33-17-19;26-24-28-15-20(16-29-24)17-5-7-21(8-6-17)25(9-11-32-12-10-25)23(31)30-22-13-18-3-1-2-4-19(18)14-27-22;24-19-11-17(5-6-18(19)23(25,26)27)31-20(32)22(7-9-33-10-8-22)16-3-1-14(2-4-16)15-12-29-21(28)30-13-15;1-14-3-8-18(23-11-14)26-19(27)21(9-2-10-21)17-6-4-15(5-7-17)16-12-24-20(22)25-13-16;1-12-13(2)27-19(24-12)25-17(26)20(8-3-9-20)16-6-4-14(5-7-16)15-10-22-18(21)23-11-15;1-12-9-23-18(26-12)24-16(25)19(7-2-8-19)15-5-3-13(4-6-15)14-10-21-17(20)22-11-14/h1-6,15-17H,7-14H2,(H,34,36)(H2,31,32,33);1-8,13-16H,9-12H2,(H2,26,28,29)(H,27,30,31);1-6,11-13H,7-10H2,(H,31,32)(H2,28,29,30);3-8,11-13H,2,9-10H2,1H3,(H2,22,24,25)(H,23,26,27);4-7,10-11H,3,8-9H2,1-2H3,(H2,21,22,23)(H,24,25,26);3-6,9-11H,2,7-8H2,1H3,(H2,20,21,22)(H,23,24,25) |
| InChIKey | GOYPUPPINIRWEO-UHFFFAOYSA-N |
| XLogP | 23.70 |
| TPSA | 577.12 Ų |
| H-Bond Donors | 12 |
| H-Bond Acceptors | 35 |
| Rotatable Bonds | 25 |
| Heavy Atoms | 183 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2517.85 |
| LogP ≤ 5 | 23.70 |
| H-Bond Donors ≤ 5 | 12 |
| H-Bond Acceptors ≤ 10 | 35 |